Jonathan Wygant, VP and Chief Accounting Officer of Veracyte, Inc., filed a statement of changes in beneficial ownership on October 29, 2026, reporting a share withholding transaction dated October 28, 2026.

Key Highlights

  • Reporting person: Jonathan Wygant, VP and Chief Accounting Officer of Veracyte, Inc. (NASDAQ:VCYT)
  • Transaction date: October 28, 2026, with the filing signed and submitted on October 29, 2026
  • Shares withheld: 1,306 shares of common stock disposed of (code F) at a price of $50.31 per share
  • Purpose of withholding: According to the filing, the shares were withheld to satisfy tax withholding obligations in connection with the vesting of certain restricted stock units and "does not represent a sale"
  • Resulting ownership: Wygant directly beneficially owned 41,920 shares of common stock following the reported transaction
  • No derivative securities: No transactions were reported in Table II covering derivative securities such as options or warrants

Wygant RSU Vesting and Tax Withholding at Veracyte

According to the filing, Jonathan Wygant, who serves as VP and Chief Accounting Officer of Veracyte, Inc., reported a disposition of 1,306 shares of common stock on October 28, 2026, under transaction code F. The filing explains that this transaction represents shares withheld by the company to cover the reporting person's tax withholding obligations arising from the vesting of certain restricted stock units on that date, and explicitly states it "does not represent a sale."

Veracyte, Inc., listed on NASDAQ under the symbol VCYT and headquartered at 6000 Shoreline Court, Suite 300, South San Francisco, California 94080, is the issuer identified in the filing. The withholding price recorded for the transaction was $50.31 per share. Following the withholding, the filing reports that Wygant held 41,920 shares of Veracyte common stock directly. The filing was made by one reporting person and was not an amendment to a prior filing. No indirect ownership or derivative security positions were reported.

The filing was signed by Jonathan Wygant on October 29, 2026. No Rule 10b5-1 plan box was checked in connection with this transaction, and the reporting person is identified solely as an officer, not as a director or 10% owner of the issuer.

What Was Disclosed

Veracyte's Chief Accounting Officer Jonathan Wygant reported the withholding of 1,306 shares of common stock at $50.31 per share on October 28, 2026, to cover taxes on vested restricted stock units, leaving him with 41,920 directly held shares.